Pembrolizumab in Untreated Extensive SCLC (REACTION)

Clinical Trial ID NCT02580994

Rank	Title	Journal	Year	PubWeight™‹?›
1	Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?	ESMO Open	2016	0.77